Ahmad Sadr
Corporate Officer/Principal chez APELLIS PHARMACEUTICALS, INC.
Profil
Ahmad Sadr occupe le poste de vice-président des opérations techniques chez Apellis Pharmaceuticals, Inc. Par le passé, M. Sadr a occupé le poste de vice-président des opérations techniques chez Vision Medicines, Inc. et celui de directeur de la fabrication externalisée chez Portola Pharmaceuticals, Inc. M. Sadr a obtenu un diplôme d'études supérieures de l'université Widener et un diplôme de premier cycle de l'université du Maryland.
Postes actifs de Ahmad Sadr
| Sociétés | Poste | Début |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Anciens postes connus de Ahmad Sadr
| Sociétés | Poste | Fin |
|---|---|---|
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2017 |
Vision Medicines, Inc.
 Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Chief Tech/Sci/R&D Officer | 01/05/2016 |
Formation de Ahmad Sadr
| University of Maryland | Undergraduate Degree |
| Widener University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Vision Medicines, Inc.
Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Health Technology |
